Related Experiment Video

Updated: Jul 10, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic

Andy C Rawstron1, Fiona Bennett, Peter Hillmen

  • 1HMDS, Leeds Teaching Hospitals, Leeds, UK. andy.rawstron@hmds.org.uk

British Journal of Haematology
|November 21, 2007
PubMed

Insights

A common B-cell population, monoclonal B-cell lymphocytosis (MBL), shares markers with chronic lymphocytic leukemia (CLL). Some MBL patients may progress to requiring treatment, necessitating research into risk factors.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • A CD5(+)23(+) monoclonal B-cell population, phenotypically identical to chronic lymphocytic leukemia (CLL), is found in ~3% of adults.
  • This CLL-phenotype monoclonal B-cell lymphocytosis (MBL) shares numerous protein markers and genetic features with indolent CLL.
  • MBL is detected in ~10% of individuals investigated for lymphocytosis.

Purpose of the Study:

  • To investigate the biological association between CLL-phenotype MBL and chronic lymphocytic leukemia.
  • To understand the progression patterns and early disease mechanisms of MBL.
  • To identify risk factors for disease progression in MBL patients.

Main Methods:

  • Phenotypic analysis of monoclonal B-cell populations using standard CLL diagnostic markers and protein expression.
  • Genetic assessment, including immunoglobulin heavy chain gene analysis, to study clonal diversification.
  • Longitudinal observation of patients with CLL-phenotype MBL to track cell counts and treatment needs.

Main Results:

  • CLL-phenotype MBL cells exhibit identical markers to CLL, suggesting a close biological relationship.
  • Intraclonal variation analysis indicates clonal diversification, not selection, in early MBL progression.
  • A subset of MBL patients show increasing cell counts over time, with some progressing to requiring treatment.

Conclusions:

  • CLL-phenotype MBL represents an indolent condition biologically linked to CLL.
  • Early MBL progression may involve clonal diversification, and some patients are at risk of developing overt CLL.
  • Further research is needed to identify factors predicting disease progression in MBL patients.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...